1 Definition and scope of quiescence markers

Quiescence markers are measurable molecular, cellular, or phenotypic features used to identify and track cells that are in a quiescent state—typically characterized by non-proliferation or substantially reduced proliferation. Rather than functioning as a simple on/off label, quiescence is often treated as a regulated condition with internal transitions, requiring marker systems that reflect both state identity and timing.

In practice, quiescence markers are used to (i) distinguish quiescent cells from actively cycling counterparts, (ii) quantify the proportion of cells occupying quiescent-like states, (iii) assess how quickly cells enter quiescence after an intervention and how they exit upon permissive cues, and (iv) compare state changes across perturbations such as nutrient limitation, cytokine withdrawal, or drug exposure.

1.1 What “quiescence” means across cell types

“Quiescence” can refer to different biological realities depending on the tissue and lineage context. In many systems, it denotes a reversible low-proliferation program maintained without continuous cell division. In others, the label is used more broadly to describe a low-cycling phase where cells preserve functional capacity even when growth signals are reduced.

Operationally, studies define quiescence using measurable behavior (e.g., lack of DNA replication, absence of cycling markers) combined with supporting features (metabolic slowdown, chromatin remodeling, or transcriptional programs). This flexibility reflects that quiescent states can vary in depth and stability across cell types.

1.2 Types of markers (molecular, cellular, functional, imaging-based)

Quiescence markers span multiple readout classes:

  • Molecular markers: gene-expression signatures, protein abundance, phosphorylation states, or epigenetic marks.
  • Cellular markers: changes in cell-cycle distribution, cell size, granularity, or viability-linked features.
  • Functional markers: capacity for proliferation upon stimulation after a quiescence period.
  • Imaging-based markers: subcellular localization patterns, morphology, and live-cell trajectories compatible with low proliferation.

Because different readouts capture different facets of quiescence, researchers often combine markers rather than relying on a single metric.

1.3 Distinguishing quiescence from senescence and dormancy

Quiescence is commonly distinguished from senescence and dormancy through reversibility and underlying mechanisms. Senescence typically entails a durable proliferation arrest accompanied by characteristic damage-response features and altered secretory activity. Dormancy may overlap conceptually with low activity states, but the term is also used in contexts such as stem-cell niche behavior or treatment-induced non-growing conditions where reversibility and molecular drivers can differ.

A robust interpretation strategy uses multiple markers and includes functional testing (e.g., recovery of cycling capacity) to clarify whether observed arrest reflects a reversible quiescent program or a more terminal-like state.

2 Biological basis of marker expression

Quiescence markers arise because low-proliferation states are maintained by coordinated changes in gene regulation, cell-cycle control, metabolism, and chromatin architecture. Marker expression therefore reflects both the current state and the regulatory logic that stabilizes it.

2.1 Gene-expression programs associated with quiescence

Quiescent cells often show stable transcriptional programs that reduce proliferation-associated gene activity while enhancing pathways related to stress tolerance, maintenance, and resource conservation. Compared with cycling cells, quiescent profiles frequently exhibit reduced expression of transcripts linked to DNA replication, mitosis, and growth-factor responsiveness.

Because quiescence can be established by diverse stimuli (withdrawal, contact inhibition, stress responses, or niche signaling), the exact gene modules can differ. Nonetheless, many systems share broad features: diminished cell-cycle transcription, altered ribosome biogenesis, and shifts in stress-handling genes.

2.2 Cell-cycle regulators and checkpoint involvement

Quiescence is closely connected to the cell-cycle regulatory network. In many models, cells exit the proliferative loop by entering a non-cycling configuration where key proliferative drivers are suppressed and inhibitory controls dominate.

2.2.1 Transcriptional activity and promoter states

Promoter and enhancer activity patterns can shift in quiescence. Proliferation-related promoters may become less active through changes in transcription factor availability, chromatin accessibility, and cofactor recruitment. Conversely, promoters supporting maintenance programs may retain or gain activity, supporting steady-state quiescent identity.

These promoter-level changes are a major reason transcriptional profiling can reveal quiescence even when cell-cycle behavior alone is ambiguous.

2.3 Metabolic and signaling changes linked to quiescence

A hallmark of many quiescent states is altered metabolic demand. Cells in low proliferation typically reduce biosynthetic throughput and remodel energy usage to support survival and readiness for re-entry when conditions improve.

2.3.1 Mitochondrial activity and redox balance

Mitochondrial respiration and reactive oxygen species handling can shift during quiescence. Some quiescent states show reduced respiration rates and altered redox buffering, influencing susceptibility to oxidative stress and determining recovery kinetics. These changes can produce marker patterns observable via metabolic dyes, redox reporters, or transcriptional pathways associated with oxidative stress management.

2.4 Chromatin organization and epigenetic features

Quiescent identity often involves chromatin states that stabilize low-cycling transcriptional outputs. Epigenetic regulation can help maintain reduced proliferation even after transient fluctuations in upstream signaling.

2.4.1 Nucleosome accessibility and histone modifications

Quiescence-associated epigenetic features may include altered nucleosome accessibility at key regulatory elements and changes in histone marks that affect transcriptional competence. These modifications can bias cells toward maintenance programs and away from replication gene activation, thereby supporting stable marker profiles during low proliferation.

Because epigenetic landscapes can vary by lineage and quiescence trigger, interpretation typically benefits from comparing multiple markers aligned to the same state transition.

3 Common classes of quiescence markers

Quiescence markers are most informative when they are interpreted as a set reflecting complementary dimensions of the state: cell-cycle status, damage or stress context, metabolic state, surface phenotype, and RNA-level identity.

The most direct evidence for quiescence often involves absence or reduction of cycling features.

3.1.1 Ki-67 negativity as an indicator of non-cycling state

Ki-67 is a widely used proliferation marker. Cells that are Ki-67 negative are typically interpreted as being outside active proliferation. While Ki-67 does not by itself define the regulatory reason for arrest, it provides a practical separation between cycling and non-cycling populations in many experimental contexts.

3.2 DNA damage response and repair-associated indicators

Some quiescent-like conditions arise alongside stress, and certain quiescence frameworks incorporate DNA damage response (DDR) readouts. However, DDR markers can also indicate senescence or persistent arrest, so context is essential.

γH2AX is a phosphorylation mark associated with DNA damage signaling. In quiescence studies it is often treated as context-dependent: transient DDR activation may occur during stress-induced low activity, while sustained or high-intensity γH2AX can suggest longer-term damage-driven arrest. A common strategy is to interpret γH2AX alongside markers of proliferative recovery capacity and other DDR or repair indicators.

3.3 Metabolic quiescence markers

Metabolic quiescence markers capture the slowdown in biosynthesis and energy usage typical of non-proliferating states.

3.3.1 Reduced proliferation-linked metabolic signatures

Cells in quiescence may show reduced uptake of proliferation-associated nutrients, lower mitochondrial activity, or shifted metabolite distributions. At the transcript level, corresponding pathways include decreased expression of genes supporting nucleotide synthesis, translation, and growth-linked signaling.

In assays, these states can be measured using metabolic dyes, flux proxies, or gene modules that correlate with low anabolic activity.

3.4 Surface and secreted markers

Surface markers are often valued for their compatibility with cell sorting and population-level quantification. Secreted markers can provide additional context but may be harder to assign to individual cells.

3.4.1 Flow cytometry–friendly surface antigen panels

Flow cytometry panels typically combine quiescence-associated surface markers with exclusion markers such as viability dyes and markers for cycling or differentiation status. The resulting multicolor strategy supports gating schemes that enrich for non-cycling populations and enables quantitative comparisons across treatments.

Because surface phenotypes can drift with differentiation and environmental conditions, panels are usually validated within each system.

3.5 RNA-based markers

RNA profiling offers a high-dimensional view of quiescence programs, including subtle differences between related low-proliferation states.

3.5.1 Single-cell transcriptomic quiescence signatures

Single-cell transcriptomics can identify quiescence-related transcriptional programs and distinguish them from other non-proliferating states. Approaches such as module scoring, clustering, and trajectory inference are used to define quiescence signatures and track transitions as cells move between cycling and low-proliferation modes.

RNA-based markers are powerful but require careful handling of technical variation and careful interpretation of whether transcriptional quieting matches functional quiescence.

4 Experimental strategies to detect quiescence

Detection strategies combine marker measurement with experimental design that aligns timing, stimulus conditions, and reference populations. The same quiescent label can emerge through different pathways, so detection methods are often multi-modal.

4.1 Flow cytometry approaches

Flow cytometry enables rapid quantification of marker expression across large cell numbers, including surface proteins and intracellular proliferation-related signals.

4.1.1 Gating strategies to separate quiescent from cycling populations

Gating typically begins with live-cell selection, followed by exclusion of debris and doublets. Proliferation-related markers (such as Ki-67) and DNA content or cell-cycle distribution metrics can then separate cycling from non-cycling populations. Researchers often incorporate additional markers indicating cellular stress or metabolic state to refine the quiescence category and avoid conflating low cycling with other arrests.

4.2 Immunostaining and microscopy

Immunostaining provides spatial context and can reveal subcellular features not captured by flow. Microscopy also supports morphology-based assessments that correlate with quiescent behavior.

4.2.1 Live-cell imaging readouts for quiescent behaviors

Live-cell approaches can track morphology, motility, or reporter-based transcriptional activity over time. Readouts such as reduced division frequency, stability of reporter expression, or characteristic cellular shape changes support identification of quiescent trajectories and timing of entry or exit.

4.3 Transcriptomic profiling

Transcriptomic approaches can capture quiescence identity through program-level signatures rather than single markers.

4.3.1 Differential expression and module scoring for quiescence programs

Differential expression analyses identify genes whose activity distinguishes quiescent-like cells from cycling populations. Module scoring aggregates expression across sets of genes associated with known programs, providing a quantitative quiescence score per cell or sample. This method can reveal gradations in quiescence rather than binary classification.

4.4 Functional assays coupled to marker readouts

Functional testing links marker identity to biological capability and helps separate reversible quiescence from irreversible states.

4.4.1 Proliferation re-entry capacity after recovery

A common design involves inducing quiescence using a defined condition, isolating cells based on marker status, and then returning them to proliferation-permissive conditions. Recovery kinetics—such as time to first division or expansion rates—serve as functional confirmation that marker-defined cells are truly in a quiescent, re-activatable state.

5 Validation and interpretation

Validation is central because marker behavior is context-dependent and can overlap with other non-proliferative conditions. Interpretation requires specificity testing, temporal analysis, and careful quantification.

5.1 Marker specificity and context dependence

A quiescence marker may be specific in one system but ambiguous in another. Differences in lineage, stimulus, and experimental stress levels can change how strongly a marker correlates with true quiescent behavior.

Therefore, specificity is established by evaluating marker performance against both cycling status and functional recovery, ideally across multiple conditions.

5.2 Controls for distinguishing quiescence from arrest

Controls commonly include actively cycling reference populations, alternative arrest conditions (e.g., growth-factor independent arrest), and stress conditions that might induce irreversible changes. Where feasible, researchers add functional assays to determine whether non-cycling marker-positive cells can re-enter the cycle.

5.3 Temporal dynamics: marker changes during entry/exit

Quiescence is dynamic. Markers can appear early during entry, stabilize later, or change during exit. Time-course experiments help map the sequence of events and prevent misclassification due to measurement at an intermediate stage.

Temporal profiling also supports the identification of markers that best represent stable quiescent identity versus transient transitions.

5.4 Quantification and statistical considerations

Quantifying quiescence requires robust measurement practices that respect variability between samples, runs, and instruments.

5.4.1 Batch effects in multi-sample marker measurement

Batch effects can arise from differences in staining, instrument settings, sequencing depth, or sample handling. These effects can distort marker distributions and weaken comparisons across experiments. Mitigation approaches include standardized protocols, appropriate reference samples, and statistical correction techniques for multi-batch datasets.

5.5 Pitfalls and common misinterpretations

Common pitfalls include equating low proliferation with quiescence without functional confirmation, using single markers despite known overlap with other states, and interpreting DDR or metabolic changes as purely quiescent when they may reflect stress or damage.

Another frequent challenge is assuming marker thresholds are transferable between platforms. Without validation, marker positivity thresholds can misrepresent the true biological distribution.

6 Experimental design considerations

Good quiescence marker studies align biological assumptions with operational definitions, ensuring that detection matches the intended state.

6.1 Selecting an appropriate marker set

Marker selection should reflect the biological question. For population-level tracking, a combination of proliferation markers and a supportive quiescence indicator (metabolic or surface phenotype) can be effective. For mechanistic studies, adding RNA or chromatin readouts can provide insight into regulatory underpinnings.

The marker set is often chosen based on measurement feasibility, expected quiescence depth, and whether reversibility is being tested.

6.2 Defining quiescence operationally for the system

Researchers define quiescence operationally using a combination of marker status and functional criteria. A practical definition may include non-cycling behavior (e.g., Ki-67 negativity), maintenance of viability, and the ability to proliferate after recovery. This definition enables consistent interpretation and comparison across experimental repeats.

6.3 Sampling timepoints and environmental conditions

Timing and culture conditions strongly influence marker expression. Quiescence entry and exit can occur on different timescales depending on stimulus strength and cell type.

6.3.1 Nutrient and growth factor withdrawal paradigms

Nutrient limitation and growth factor withdrawal are common induction methods. These interventions can produce quiescence-like profiles, but they can also trigger stress responses. Using appropriately matched controls and monitoring stress-associated markers helps distinguish nutrient- or signaling-dependent quiescence from general stress-induced arrest.

6.4 Perturbation studies to test causality

Perturbations test whether marker-defined states are regulated by specific pathways rather than merely correlated with low proliferation.

6.4.1 Knockdown/overexpression and readout consistency checks

Genetic perturbations, such as knockdown or overexpression, can affect both marker expression and proliferative behavior. Causality claims are strengthened by verifying that changes in marker status align with consistent shifts in functional recovery and with concordant changes across complementary readouts.

7 Data analysis and reporting standards

Analysis methods should preserve interpretability while ensuring reproducibility. Reporting standards help others compare results across platforms.

7.1 Normalization and reference populations

Normalization typically uses reference populations such as untreated cycling controls or stable internal standards. In single-cell studies, normalization methods and careful handling of sequencing depth are important for ensuring that quiescence scoring reflects biological variation rather than technical scaling.

7.2 Thresholding vs continuous scoring of marker expression

Some workflows use discrete thresholds (e.g., Ki-67 negative/positive), while others use continuous quiescence scores derived from module expression or imaging reporter intensity. Continuous representations can capture gradations, whereas threshold-based classifications can simplify comparisons but may hide intermediate states.

Many studies report both approaches or justify the chosen strategy based on biological expectations and assay noise.

7.3 Reproducibility across platforms (flow, RNA-seq, imaging)

Cross-platform reproducibility requires mapping between readouts. For example, a marker set defined by flow cytometry may correspond to transcript modules in RNA-seq data, but technical differences can alter absolute levels.

Validation often includes comparing relative trends across conditions and confirming that marker-defined populations show consistent functional behavior across platforms.

7.4 Reporting marker panels and validation outcomes

Transparent reporting includes listing marker components, gating criteria or scoring methods, and the rationale for defining quiescence. Validation outcomes should state how specificity was assessed, what controls were used, and how functional recovery supported the operational definition.

8 Applications of quiescence marker research

Quiescence markers support a broad set of biological and applied research goals, especially where cell state transitions determine function.

8.1 Stem cell biology and tissue homeostasis

In stem-cell systems, quiescence markers help identify slowly cycling compartments that preserve long-term tissue maintenance capacity. By tracking marker-positive states over time, researchers can study how niche signals and injury responses regulate the balance between quiescence and proliferation.

Quiescence markers are used to evaluate how tissue repair processes engage low-cycling cells and how aging-associated changes may shift cell-state distributions. In this framing, the focus remains on cellular behavior and measurable outcomes rather than on contentious societal interpretations.

8.3 Cancer research: treatment-induced quiescent states

In oncology research, certain therapies can induce low-proliferation phenotypes. Quiescence markers can help quantify these state shifts and examine whether tumor cells in a low-cycling mode survive treatment and later resume growth.

Interpretation emphasizes functional reactivation potential and integrates markers that distinguish quiescence-like behavior from irreversible arrest.

8.4 Drug discovery and screening for state transitions

Quiescence markers enable screening for compounds that promote or reverse quiescent states. For example, researchers may assess whether candidate treatments cause durable non-proliferation or instead trigger reversible low-cycling programs that permit recovery.

Marker-based readouts support dose-response testing and time-course profiling of state transitions.

8.5 Biotechnology applications (e.g., optimizing cell culture states)

In cell culture and bioprocessing, quiescence markers can inform strategies to maintain stable production-relevant cell states. Monitoring low-proliferation conditions can improve consistency in yields, reduce culture variability, and help schedule downstream processes when cells are in predictable physiological phases.

9 Emerging directions

Advances in measurement technologies and computation are expanding marker development from single features to integrated, predictive state models.

9.1 Multi-marker and single-cell quiescence atlases

Quiescence atlases aim to compile marker-defined states across cell types and conditions. Multi-marker and single-cell integration helps address heterogeneity by identifying shared program structures and context-specific variations.

Such atlases can support cross-study comparisons when standardized definitions and validation criteria are applied.

9.2 Machine learning approaches to classify quiescence states

Machine learning methods can combine multiple readouts—marker expression, RNA modules, imaging features—to classify quiescence states and infer transitions. When trained and validated appropriately, these approaches can improve sensitivity for low-proliferation states that are not captured by simple thresholding.

9.3 Standardized benchmarks for marker performance

Benchmarks evaluate marker specificity, robustness to technical variation, and correlation with functional recovery. Standardization efforts focus on defining performance metrics across platforms and ensuring that comparisons are meaningful across labs.

9.4 Prospects for causative quiescence signatures

A key goal for the field is identifying not only correlates of quiescence but also causal programs that drive stable low-proliferation identity. Emerging strategies pair marker discovery with perturbation experiments to test whether specific gene modules, metabolic shifts, or chromatin features actively maintain quiescence or merely report it.

As validated causative signatures emerge, quiescence markers may become more predictive tools for controlling cell-state transitions in research and applied settings.